VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 143 filers reported holding VIKING THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,843,363 | +0.7% | 618,190 | +47.5% | 0.02% | +5.9% |
Q2 2023 | $6,794,811 | -41.3% | 419,174 | -39.7% | 0.02% | -48.5% |
Q1 2023 | $11,583,488 | -2.6% | 695,705 | -45.0% | 0.03% | -10.8% |
Q4 2022 | $11,892,767 | +343.3% | 1,265,188 | +28.3% | 0.04% | +311.1% |
Q3 2022 | $2,683,000 | -10.9% | 986,323 | -5.3% | 0.01% | -10.0% |
Q2 2022 | $3,011,000 | -19.3% | 1,042,002 | -16.2% | 0.01% | -9.1% |
Q1 2022 | $3,732,000 | -13.1% | 1,244,092 | +33.3% | 0.01% | +22.2% |
Q4 2021 | $4,294,000 | -22.0% | 933,481 | +6.5% | 0.01% | -25.0% |
Q3 2021 | $5,503,000 | +11.0% | 876,324 | +5.8% | 0.01% | +9.1% |
Q2 2021 | $4,959,000 | -30.2% | 827,944 | -26.3% | 0.01% | -38.9% |
Q1 2021 | $7,102,000 | +334.6% | 1,122,831 | +286.9% | 0.02% | +260.0% |
Q4 2020 | $1,634,000 | +334.6% | 290,220 | +349.1% | 0.01% | +400.0% |
Q3 2020 | $376,000 | -88.7% | 64,624 | -86.0% | 0.00% | -93.8% |
Q2 2020 | $3,330,000 | +11.7% | 461,900 | +18.6% | 0.02% | +33.3% |
Q4 2018 | $2,981,000 | – | 389,620 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 450,900 | $2,624,000 | 0.85% |
Sio Capital Management, LLC | 709,780 | $4,131,000 | 0.82% |
KNOTT DAVID M | 218,102 | $1,269,000 | 0.74% |
ArrowMark Colorado Holdings LLC | 7,988,635 | $46,494,000 | 0.44% |
Park West Asset Management LLC | 1,457,507 | $8,483,000 | 0.33% |
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 1,657 | $10,000 | 0.18% |
Virtus ETF Advisers LLC | 42,507 | $247,000 | 0.13% |
Cornerstone Capital, Inc. | 125,465 | $730,000 | 0.10% |
L & S Advisors Inc | 114,988 | $669,000 | 0.09% |
EXANE DERIVATIVES | 44,877 | $261,170,000 | 0.08% |